Follow the 고바이오랩 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 고바이오랩 has published 16 reports. The latest transaction was disclosed on 31 May 2024 (Sale). Among the most active insiders: 고광표. The full history is accessible without an account.
16
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
15 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
고바이오랩 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for healthcare.